TR199900984T2 - Benzensülfonamid türevleri ve adi geçen türevleri içeren ilaçlar. - Google Patents

Benzensülfonamid türevleri ve adi geçen türevleri içeren ilaçlar.

Info

Publication number
TR199900984T2
TR199900984T2 TR1999/00984T TR9900984T TR199900984T2 TR 199900984 T2 TR199900984 T2 TR 199900984T2 TR 1999/00984 T TR1999/00984 T TR 1999/00984T TR 9900984 T TR9900984 T TR 9900984T TR 199900984 T2 TR199900984 T2 TR 199900984T2
Authority
TR
Turkey
Prior art keywords
revleri
alkyl group
lfonamid
benzens
eren
Prior art date
Application number
TR1999/00984T
Other languages
English (en)
Inventor
Yasuda Shingo
Ogawa Nobuo
Sakurai Shunichiro
Original Assignee
Hokuriku Seiyaku Co.; Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Seiyaku Co.; Ltd. filed Critical Hokuriku Seiyaku Co.; Ltd.
Publication of TR199900984T2 publication Critical patent/TR199900984T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

Asagidaki genel formül (1) tarafindan temsil edilen yeni benzensülfonamid türevlerinde: R1 hidrojen atomu, bir halojen atomu, düsük bir alkil grubu düsük bir alkoksil grubu ya da nitro grubunu, R2 bir ya da daha fazla flor atomu ile yedeklenen bir C4-C8 alkil grubunu; R3 hidrojen atomu ya da düsük bir alkil grubunu; X sülfür atomu ya da CH=CH ile temsil edilen bir grubu; n de z'den 4'e kadar bir sayiyi temsil etmektedir. Aktif madde olarak adi geçen bilesikten olusan ilaçlar, tromboz, astim ve allerjik hastaliklarin koruyucu ve veya iyilestirici tedavisinde kullanilabilir.
TR1999/00984T 1996-11-13 1997-11-12 Benzensülfonamid türevleri ve adi geçen türevleri içeren ilaçlar. TR199900984T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31710996 1996-11-13
JP9269234A JPH10195038A (ja) 1996-11-13 1997-09-16 ベンゼンスルホンアミド誘導体及びそれを含有する医薬

Publications (1)

Publication Number Publication Date
TR199900984T2 true TR199900984T2 (tr) 1999-07-21

Family

ID=26548679

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00984T TR199900984T2 (tr) 1996-11-13 1997-11-12 Benzensülfonamid türevleri ve adi geçen türevleri içeren ilaçlar.

Country Status (17)

Country Link
EP (1) EP0943606A1 (tr)
JP (1) JPH10195038A (tr)
KR (1) KR20000053254A (tr)
CN (1) CN1244859A (tr)
AU (1) AU716395B2 (tr)
BG (1) BG103395A (tr)
BR (1) BR9712763A (tr)
CA (1) CA2271673A1 (tr)
CZ (1) CZ169399A3 (tr)
EA (1) EA199900460A1 (tr)
ID (1) ID21835A (tr)
IL (1) IL129574A0 (tr)
NO (1) NO992316L (tr)
PL (1) PL333287A1 (tr)
SK (1) SK61199A3 (tr)
TR (1) TR199900984T2 (tr)
WO (1) WO1998021177A1 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007528917A (ja) * 2004-01-30 2007-10-18 グレート・レークス・ケミカル・コーポレーション 製造方法並びにシステム、組成物、界面活性剤、モノマー単位、金属錯体、燐酸エステル、グリコール、水性皮膜形成フォーム、及びフォーム安定剤
EP1718722A4 (en) * 2004-01-30 2012-08-08 Du Pont PRODUCTION PROCESSES AND SYSTEMS, COMPOSITIONS, TENSIDES, MONOMER UNITS, METAL COMPLEXES, PHOSPHATESTER, GLYCOLS, AQUEOUS FILM-FORMING FOAMS AND FOAM STABILIZERS
KR20070094981A (ko) * 2004-01-30 2007-09-27 그레이트 레이크스 케미칼 코퍼레이션 조성물, 할로겐화 조성물, 화학적 제조 및 텔로머화 방법
JP2007526249A (ja) * 2004-01-30 2007-09-13 グレート・レークス・ケミカル・コーポレーション 生産プロセスおよびシステム、組成物、界面活性剤、モノマー単位、金属錯体、リン酸エステル、グリコール、水性膜形成発泡体、および発泡安定化剤
WO2007037242A1 (ja) * 2005-09-27 2007-04-05 Kaneka Corporation 光学活性ベンジルアミン誘導体の製造方法
JP2011088825A (ja) * 2008-01-16 2011-05-06 Kaken Pharmaceutical Co Ltd 鼻閉症治療用経粘膜投与製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753505A (ja) * 1992-10-01 1995-02-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びその用途
JPH0948775A (ja) * 1995-06-02 1997-02-18 Hokuriku Seiyaku Co Ltd （２−チエニル）アルカン酸誘導体

Also Published As

Publication number Publication date
BR9712763A (pt) 1999-12-21
JPH10195038A (ja) 1998-07-28
CZ169399A3 (cs) 1999-11-17
CA2271673A1 (en) 1998-05-22
SK61199A3 (en) 1999-11-08
IL129574A0 (en) 2000-02-29
WO1998021177A1 (fr) 1998-05-22
BG103395A (en) 2000-02-29
KR20000053254A (ko) 2000-08-25
AU716395B2 (en) 2000-02-24
ID21835A (id) 1999-08-05
EP0943606A1 (en) 1999-09-22
CN1244859A (zh) 2000-02-16
NO992316D0 (no) 1999-05-12
EA199900460A1 (ru) 2000-02-28
NO992316L (no) 1999-07-12
PL333287A1 (en) 1999-11-22
AU4964597A (en) 1998-06-03

Similar Documents

Publication Publication Date Title
ATE168685T1 (de) Aminoheterocyclische derivate als antithrombotische oder antikoagulierende mittel
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
HUP9904361A2 (hu) Izobutil-gaba és származékai alkalmazása fájdalom kezelésére
DK0731085T3 (da) Stilbenderivater og farmaceutiske sammensætinger indeholdende disse
AU560579B2 (en) N-aromatic-n:-cycloalkylalkanoyl-piperazines
DE60107435D1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
DK0759919T3 (da) Azolidindioner som antihyperglykæmiske midler
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
TR199902495T2 (tr) Bilesimler.
TR200001010T2 (tr) Ürokinaz önleyicileri olan izokinolinler.
ATE224372T1 (de) Substituierte 6-alkylphenanthridine
SE8406302D0 (sv) New aminoguanidine derivatives and a process for the preparation thereof
TR199900984T2 (tr) Benzensülfonamid türevleri ve adi geçen türevleri içeren ilaçlar.
DE69519385D1 (de) Chinazolinon-arzneimittel sowie deren verwendung
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
DK624989D0 (da) Hidtil ukendte forbindelser
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
TR199902955T2 (tr) Anjiogenez inhibitörü tiadiazolil piridazin türevleri.
ATE47135T1 (de) Antikonvulsive mittel.
TR199902507T2 (tr) 4 Halojenli yeni steroidler, hazirlama yöntemi ve araçlari.
ATE147755T1 (de) Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten